Contrast Injectors Market by Product and Geography - Forecast and Analysis 2021-2025

The contrast injectors market share is expected to increase by USD 578.41 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 5%.

The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (consumables and contrast injectors) and geography (North America, Europe, Asia, and ROW).

The contrast injectors market report also offers information on several market vendors, including APOLLO RT Co. Ltd., Bayer AG, Bracco Spa, General Electric Co., Guerbet, LeMaitre Vascular Inc., MEDTRON AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High tech Co. Ltd., and Shenzhen Seacrown Electromechanical Co. Ltd. among others.

APOLLO RT Co. Ltd. - The company offers high-quality contrast injectors such as APO l00, APO200, and others. Under the unified segment, the company focuses on manufacturing high-quality contrast media injectors, syringes and disposables, widely used in the medical imaging market.

What will the Contrast Injectors Market Size be During the Forecast Period?

Get the Contrast Injectors Market Size Forecast by Downloading the Report Sample

Parent Market Analysis

Technavio categorizes the global contrast injectors market as a part of the global healthcare equipment market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the contrast injectors market during the forecast period. 

Contrast Injectors Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post-COVID-19 era. The increasing prevalence of diseases and related risk factors is notably driving the contrast injectors market growth. However, factors such as the high cost of contrast injectors may impede market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage. 

Key Contrast Injectors Market Driver

• One of the key factors driving growth in the contrast injectors market is the increasing prevalence of diseases and related risk factors.
• MRIs are most frequently used to examine the central nervous system (CNS), orthopedic, and cardiovascular health conditions (CVDs). They are also used to detect breast cancer.
• The prevalence and incidence of CVDs have increased across the globe. For instance, according to the data stated by the CDC in the US, 30.3 million adults were diagnosed with CVDs in 2018. CVDs directly or indirectly increase the risk of heart attacks or cardiac arrest.
• The rise in the incidences and prevalence of CVDs are, therefore, increasing the demand for contrast injectors, which would drive market growth during the forecast period. 

Key Contrast Injectors Market Challenge

• The high cost of contrast injectors will be a major challenge for the contrast injectors market during the forecast period.
• Depending upon the features and the level of technology being used, on average, the price of contrast injectors ranges between USD 25,000 and USD 50,000.
• The consumables used along with the system such as syringes, check valves, and coiled tubes can cost around USD 300-USD 500 per box. 
• In the case of high utilization, these systems may require servicing every six months. The cost of these service procedures starts at USD 1,000. Therefore, many end-users are increasingly adopting refurbished contrast injectors due to budget constraints. This trend is increasing the market share of refurbished contrast injectors and is significantly hampering the sales and growth of vendors of new contrast injectors. 

This contrast injectors market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Contrast Injectors Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain and parent market of the contrast injectors market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.

Which are the Key Regions for the Contrast Injectors Market?

Get a glance at the market share of various regions by Requesting a PDF Sample now!

40% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for contrast injectors in North America. Market growth in this region will be faster than the growth of the market in the European regions.

The US and Canada are the major revenue contributors to the contrast injectors market in North America. The growth of the contrast injectors market in North America is mainly attributed to the advanced healthcare infrastructure and the high number of medical imaging examinations involving contrast media injections being performed. This will facilitate the contrast injectors market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The lockdowns imposed due to the outbreak of COVID-19 across North America have resulted in the closing down of various industries, including those operated by the manufacturers of various medical devices, including MRI systems and CT scan systems, owing to the unavailability of labour and the disruptions in the supply of necessary raw materials required for the manufacture of MRI systems and CT scan systems. Most of the manufacturers of medical devices and consumables have started focusing on developing medical devices and other consumables required to cater to the demand from healthcare facilities for diagnosing and treating patients with COVID-19. This has resulted in the reduced demand for many other medical devices, including contrast injectors, which slowed down the growth of the regional market in focus to a certain extent in 2020. However, the situation is expected to stabilize during the rest of the forecast period once the pandemic is contained.

What is the Fastest-Growing Product Segment in the Contrast Injectors Market?

To gain insights on the market contribution of various segments Request a PDF Sample

The contrast injectors market share growth by the consumables segment will be significant during the forecast period. The consumables segment is expected to grow steadily during the forecast period. This can be mainly attributed to the increasing demand for single-use consumables; the increasing number of computed tomography (CT), magnetic resonance imaging (MRI), and angiography procedures; and the rising adoption of contrast injectors. For instance, the single-use and multiple-use consumables offered by Guerbet are OptiVantage single-use, OptiVantage multiple-use, and OptiOne.

This report provides an accurate prediction of the contribution of all the segments to the growth of the contrast injectors market size and actionable market insights on the post-COVID-19 impact on each segment. 

 

Contrast Injectors Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 5%
Market growth 2021-2025	$ 578.41 million
Market structure	Fragmented
YoY growth (%)	5.00
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 40%
Key countries	US, UK, Germany, China, and Canada
Competitive landscape	Leading companies, Competitive Strategies, Consumer engagement scope
Key companies profiled	APOLLO RT Co. Ltd., Bayer AG, Bracco Spa, General Electric Co., Guerbet, LeMaitre Vascular Inc., MEDTRON AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High tech Co. Ltd., and Shenzhen Seacrown Electromechanical Co. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Contrast Injectors Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive contrast injectors market growth during the next five years
• Precise estimation of the contrast injectors market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behaviour
• The growth of the contrast injectors market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive analysis of factors that will challenge the growth of contrast injectors market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch